Kiran R. Vij
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kiran R. Vij has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Marianna B. Ruzinova
Washington University in St. Louis 3 Department of Pathology and Immunology St. Louis, MO
44 shared publications - Jacqueline L. Mudd
Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
43 shared publications - Ryan C. Fields
Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA
43 shared publications - Thomas Walsh
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
43 shared publications - Annie N. Samraj
Division of Transfusion Medicine, Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, USA
23 shared publications - David G. DeNardo
Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA
23 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S10 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S10. Role of APC:Treg:CTL three-cell-type clusters.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S10 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S10. Role of APC:Treg:CTL three-cell-type clusters.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S11 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S11. Correlation of spatial niches with T cell receptor repertoire clonality.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S11 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S11. Correlation of spatial niches with T cell receptor repertoire clonality.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S5 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S5. Spatial transcriptomics of CRC and NSCLC using Xenium immuno-oncology panel.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S5 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S5. Spatial transcriptomics of CRC and NSCLC using Xenium immuno-oncology panel.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S4 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S4. Spatial transcriptomics of PDAC using Xenium immuno-oncology panel.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S4 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S4. Spatial transcriptomics of PDAC using Xenium immuno-oncology panel.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S7 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S7. Triads are enriched for functional cell types in other spatial transcriptomics datasets.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S7 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S7. Triads are enriched for functional cell types in other spatial transcriptomics datasets.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S14 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S14. Association between spatial niches and recurrence-free survival.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S14 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S14. Association between spatial niches and recurrence-free survival.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Data from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Effective antitumor immunity ultimately depends on the priming and activation of tumor-specific cytotoxic CD8+ T cells; however, the role of intratumoral cell–cell immune interactions remains incompletely understood. Recent work has revealed that the temporospatial co-localization of dendritic cells (DC), T helper (Th) cells, and cytotoxic T lymphocytes (CTL) within the tumor immune microenvironment following immune checkpoint blockade correlates with clinical response. In this study, we report the integration of more than 1 million spatially resolved single-cell profiles across six spatial proteomic and transcriptomic assays, which demonstrated that DC:Th:CTL three-cell-type clusters were common even in immunotherapy-naïve and highly desmoplastic tumors, such as fibrolamellar carcinoma and pancreatic ductal adenocarcinoma. We found that these immune triads were enriched for functionally important type 1 conventional DC, mature DCs enriched in immunoregulatory molecules, CXCL13+ Th, and GZMK+ effector CTL phenotypes. Subsequent multiplex immunofluorescence imaging of more than 450 primary pancreatic ductal adenocarcinoma tumors showed that the density of antigen-presenting cell:Th:CTL three-cell-type clusters was correlated with intratumoral T-cell clonal expansion and improved overall survival. These findings suggest that DC:Th:CTL triads are conserved across solid tumors and highlight the importance of intratumoral spatial niches in mediating endogenous antitumor immunity.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Effective antitumor immunity ultimately depends on the priming and activation of tumor-specific cytotoxic CD8+ T cells; however, the role of intratumoral cell–cell immune interactions remains incompletely understood. Recent work has revealed that the temporospatial co-localization of dendritic cells (DC), T helper (Th) cells, and cytotoxic T lymphocytes (CTL) within the tumor immune microenvironment following immune checkpoint blockade correlates with clinical response. In this study, we report the integration of more than 1 million spatially resolved single-cell profiles across six spatial proteomic and transcriptomic assays, which demonstrated that DC:Th:CTL three-cell-type clusters were common even in immunotherapy-naïve and highly desmoplastic tumors, such as fibrolamellar carcinoma and pancreatic ductal adenocarcinoma. We found that these immune triads were enriched for functionally important type 1 conventional DC, mature DCs enriched in immunoregulatory molecules, CXCL13+ Th, and GZMK+ effector CTL phenotypes. Subsequent multiplex immunofluorescence imaging of more than 450 primary pancreatic ductal adenocarcinoma tumors showed that the density of antigen-presenting cell:Th:CTL three-cell-type clusters was correlated with intratumoral T-cell clonal expansion and improved overall survival. These findings suggest that DC:Th:CTL triads are conserved across solid tumors and highlight the importance of intratumoral spatial niches in mediating endogenous antitumor immunity.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S13 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S13. Comparison of overall survival between tissue microarray and The Cancer Genome Atlas PDAC datasets.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S13 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S13. Comparison of overall survival between tissue microarray and The Cancer Genome Atlas PDAC datasets.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S6 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S6. DC:Th:CTL three-cell-clusters are present within and outside of lymphoid aggregates.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S6 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Figure S6. DC:Th:CTL three-cell-clusters are present within and outside of lymphoid aggregates.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S1 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Table S1. Overview of datasets used in this study
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S1 from Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity
Supplemental Table S1. Overview of datasets used in this study